8-K//Current report
Adaptimmune Therapeutics PLC 8-K
Accession 0001558370-25-011925
$ADAPCIK 0001621227operating
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 4:05 PM ET
Size
321.2 KB
Accession
0001558370-25-011925
Documents
- 8-Kadap-20250906x8k.htmPrimary
8-K
- EX-10.1adap-20250906xex10d1.htm
EX-10.1
- EX-101.SCHadap-20250906.xsd
EX-101.SCH
- EX-101.LABadap-20250906_lab.xml
EX-101.LAB
- EX-101.PREadap-20250906_pre.xml
EX-101.PRE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001558370-25-011925-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLadap-20250906x8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Adaptimmune Therapeutics PLC
CIK 0001621227
Entity typeoperating
IncorporatedUnited Kingdom
Related Parties
1- filerCIK 0001621227
Filing Metadata
- Form type
- 8-K
- Filed
- Sep 7, 8:00 PM ET
- Accepted
- Sep 8, 4:05 PM ET
- Size
- 321.2 KB